1. 16 October 2026 · 17:22 IST

   SAST Save

   Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

   The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 16, 2026 for Anil Satwani, ....

   Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

2. 5 October 2026 · 17:39 IST

   Compliance Certificate Save

   Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

   Certificate Pursuant to regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.

   Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

3. 30 September 2026 · 20:09 IST

   General Save

   Symbiotec's Wholly Owned Subsidiary Knovea Pharmaceutical Enters Into Strategic Commercialization Agreement With A Leading Global Pharmaceutical Company For Dual Chamber Vial Products In The U.S.

   Symbiotec's Wholly Owned Subsidiary Knovea Pharmaceutical enters into strategic commercialization agreement with a leading global pharmaceutical company for Dual Chamber Vial ('DCV') ....

   Company Update / General View filing →

4. 29 September 2026 · 12:13 IST

   Trading Window Save

   Closure of Trading Window

   Intimation of Closure of Trading Window for the second quarter of FY 2026-27.

   Insider Trading / SAST / Closure of Trading Window View filing →

5. 29 September 2026 · 10:52 IST

   General Save

   Symbiotec Pharmalab Limited Receives Establishment Inspection Report ("EIR") From U.S. FDA For Its Manufacturing Facility In Pithampur ('SEZ') With VAI Classification

   Symbiotec Pharmalab Limited receives Establishment Inspection Report ("EIR") from U.S. FDA for its manufacturing facility in Pithampur ("SEZ") with VAI classification.

   Company Update / General View filing →

6. 28 September 2026 · 18:29 IST

   Concall Transcript Save

   Earnings Call Transcript

   Transcript of the Earnings conference call for Analysts and Investors for Q1 Financial Year 2027

   Company Update / Earnings Call Transcript View filing →

7. 22 September 2026 · 14:51 IST

   Analyst / Investor Meet Save

   Analyst / Investor Meet - Outcome

   Audio Recording Of Earnings Conference Call For Analysts And Investors held today September 22, 2026.

   Company Update / Analyst / Investor Meet View filing →

8. 22 September 2026 · 11:54 IST

   Newspaper Publication Save

   Newspaper Publication

   Pursuant to regulation 30 and 47 of SEBI Listing Regulations, the copies of newspaper publication is attached herewith.

   Company Update / Newspaper Publication View filing →

9. 21 September 2026 · 19:50 IST

   Press Release Save

   Press Release / Media Release

   Announcement under Regulation 30 (LODR) - Press Release

   Company Update / Press Release / Media Release View filing →

10. 21 September 2026 · 19:47 IST

    Investor Presentation Save

    Investor Presentation

    Announcement under Regulation 30 (LODR) - Investor Presentation

    Company Update / Investor Presentation View filing →

11. 21 September 2026 · 19:07 IST

    Results Save

    Results - Financials For Quarter Ended Jun 30, 2026

    With reference to the captioned subject, this is to inform you that Board Meeting held on September 21, 2026, have inter alia consider and approved the unaudited Standalone & Consolidated ....

    Result / Financial Results View filing →

12. 21 September 2026 · 18:32 IST

    Board Outcome Save

    Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On Monday, September 21, 2026

    Dear Sir / Madam, With reference to the captioned subject, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., Monday, September 21, 2026, ....

    Board Meeting / Outcome of Board Meeting View filing →

13. 17 September 2026 · 18:56 IST

    Analyst / Investor Meet Save

    Analyst / Investor Meet - Intimation

    Dear Sir / Madam, Pursuant to above referred Listing Regulations, we enclose herewith the details of the 'Earnings Conference Call / Analysts Meet' to discuss the financial performance ....

    Company Update / Analyst / Investor Meet View filing →

14. 11 September 2026 · 16:17 IST

    Board Meeting Save

    Board Meeting Intimation for Prior Intimation Of The Meeting Of The Board Of Directors Of Symbiotec Pharmalab Limited ('The Company') To Be Held On September 21, 2026

    Symbiotec Pharmalab Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2026 ,inter alia, to consider and approve To consider and approve ....

    Board Meeting / Board Meeting View filing →

15. 11 September 2026 · 12:30 IST

    SAST Save

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Beacon Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

16. 3 September 2026 · 13:47 IST

    General Save

    Update On Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015.

    Update on Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

    Company Update / General View filing →

17. 2 September 2026 · 17:05 IST

    SAST Save

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

18. 1 September 2026 · 15:49 IST

    Trading Window Save

    Closure of Trading Window

    Closure of trading window for the quarter ended June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

19. 1 September 2026 · 15:41 IST

    General Save

    Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015.

    Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

    Company Update / General View filing →

20. 1 September 2026 · 15:33 IST

    General Save

    Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Disclosure regarding authority to determine materiality of event or information.

    Company Update / General View filing →

21. 1 September 2026 · 08:17 IST

    New Listing Save

    Listing of Equity Shares of Symbiotec Pharmalab Ltd

    Trading Members of the Exchange are hereby informed that effective from September 01, 2026, the Equity Shares of Symbiotec Pharmalab Ltd (Scrip Code: 544889) are listed and admitted to ....

    New Listing / New Listing

RSS feed for Symbiotec Pharmalab Ltd · the 50 most recent filings